GOLDMAN SACHS GROUP INC - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 39 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$15,000
-79.7%
153,020
-23.2%
0.00%
Q2 2016$74,000
+39.6%
199,233
+43.7%
0.00%
Q1 2016$53,000
-63.4%
138,674
-62.6%
0.00%
Q4 2015$145,000
-73.8%
370,734
-61.5%
0.00%
Q3 2015$553,000
+4508.3%
962,020
+6356.5%
0.00%
Q4 2014$12,000
-96.0%
14,900
-94.9%
0.00%
Q3 2014$299,000
+14.1%
292,851
-3.8%
0.00%
Q2 2014$262,000304,3890.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2015
NameSharesValueWeighting ↓
Schonfeld Group Holdings LLC 15,000$12,0000.09%
Cutter & CO Brokerage, Inc. 94,500$77,0000.03%
PRINCETON CAPITAL MANAGEMENT LLC 25,000$20,0000.02%
STANCORP INVESTMENT ADVISERS INC 14,000$11,0000.01%
WADE G W & INC 30,000$24,0000.01%
B. Riley Wealth Advisors, Inc. 18,000$15,0000.00%
Estate Counselors, LLC 10,000$8,0000.00%
LUPO SECURITIES, LLC 800$1,0000.00%
Virtu KCG Holdings LLC 122,755$100,0000.00%
Commonwealth Equity Services, Inc 80,500$66,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders